The survey was conducted October 27-November 2, 2025, online and by telephone among a nationally representative sample of 1,350 U.S
Typically mild and improves over 1-2 weeks at each dose level Constipation : Tirzepatide slows gastric emptying, which can reduce bowel movement frequency Diarrhea : Some patients experience the opposite problem, particularly at higher doses Headaches : Common in the first week or two, usually resolving on their own Fatigue : Especially during early treatment when caloric intake drops significantly Injection site reactions : Redness, itching, or mild swelling at the injection site Dry mouth : A less discussed but fairly common side effect Muscle pain : Some patients report muscle aches, particularly during dose escalation Anxiety : Less common but reported by some patients VitaStir reviewers consistently mention that side effects are manageable
Our microarray data was analyzed by Ingenuity Pathway Analysis (IPA) for signatures and pathway information
Thats a meaningful difference compared to programs that charge a base fee and then add costs on top
Start your intake How Insurance Companies Decide GLP-1 Coverage Insurance approval for GLP-1 medications depends on several factors that vary by carrier